Rheumatology Advance Access published online on August 14, 2006
Rheumatology, doi:10.1093/rheumatology/kel253
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 ERAS, Department of Rheumatology, City Hospital, St Albans, UK
* To whom correspondence should be addressed. Objective. To examine the cause of death in a large UK inception cohort of rheumatoid arthritis (RA), and whether this was related to disease duration and severity, treatment effects or extra-articular features and complications of RA. Methods. Standard clinical, laboratory, radiological and socio-economic measures were recorded at baseline and yearly in an inception cohort started in nine centres in 1986. Date and the cause of death were based on death certificates and the comparisons made with age and sex matched population figures. Risk factors for mortality were identified from baseline measures of disease. Results. There were 459 deaths (32%) in 1429 patients followed for up to 18 yrs. Standard mortality ratio was 1.27. Survival was significantly lower in the first 7 yrs of RA. Excess mortality was seen in cardiovascular disease (31%), pulmonary fibrosis (4%) and lymphoma (2.3%). Baseline predictors for mortality were men, older age, poor function, lower socio-economic status, extra-articular features, comorbidity, rheumatoid factor, X-ray erosions, high-ESR and low-haemoglobin. Conclusion. There was a modest increase in mortality in RA, mainly in the first 7 yrs. Deaths from cardiovascular disease and pulmonary fibrosis were higher than expected, but treatment-related deaths were low. Risk factors included less favourable socio-economic status, markers of disease severity and diminished function within the first year.
Received April 10, 2006
Accepted May 25, 2006
Original Papers
Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis
A. Young 1 *, G. Koduri 1, M. Batley 1, E. Kulinskaya 2, A. Gough 1, S. Norton 2, and J. Dixey 1, on behalf of the Early Rheumatoid Arthritis Study (ERAS) group
2 Department of Statistics, University of Hertfordshire, Hertfordshire, UK
A. Young, E-mail: eras{at}whht.nhs.uk
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  U. Bergstrom, L. T. H. Jacobsson, and C. Turesson Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden Rheumatology, December 1, 2009; 48(12): 1600 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. KURODA, Y. WADA, D. KOBAYASHI, S. MURAKAMI, T. SAKAI, S. HIROSE, N. TANABE, T. SAEKI, M. NAKANO, and I. NARITA Effective Anti-TNF-{alpha} Therapy Can Induce Rapid Resolution and Sustained Decrease of Gastroduodenal Mucosal Amyloid Deposits in Reactive Amyloidosis Associated with Rheumatoid Arthritis J Rheumatol, November 1, 2009; 36(11): 2409 - 2415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Meune, E. Touze, L. Trinquart, and Y. Allanore Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies Rheumatology, October 1, 2009; 48(10): 1309 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. GARCIA-GOMEZ, J. M. NOLLA, J. VALVERDE, J. A. GOMEZ-GERIQUE, M. J. CASTRO, and X. PINTO Conventional Lipid Profile and Lipoprotein(a) Concentrations in Treated Patients with Rheumatoid Arthritis J Rheumatol, July 1, 2009; 36(7): 1365 - 1370. [Abstract] [Full Text] [PDF]
|
|